Author Question: A patient has been using latanoprost (Xalatan) ophthalmic drops. The patient tells the nurse, My ... (Read 76 times)

cabate · **on:** Jul 23, 2018

A patient has been using latanoprost (Xalatan) ophthalmic drops. The patient tells the nurse, My eyes used to be greenish-brown, but now they're brown. What will the nurse do?

a. Reassure the patient that this is a harmless side effect.
b. Report this toxic effect to the patient's provider.
c. Tell the patient that this indicates an increased risk of migraine headaches.
d. Tell the patient that this effect will reverse when the medication is withdrawn.

Question 2

A patient with chronic myeloid leukemia (CML) begins treatment with imatinib (Gleevec). Which statement by the patient indicates understanding of this medication?

a. Resistance to this drug may develop over time.
b. The intensity of side effects is dose dependent.
c. This drug does not have significant drug interactions.
d. This drug must be given intravenously.

milbourne11 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Latanoprost can cause a harmless, heightened brown pigment of the iris that stops when the medication is discontinued but does not regress. It is not a sign of a toxic reaction. It does not indicate an increased risk of developing migraines. It will not reverse.

Answer to Question 2

ANS: A
Over time, resistance to imatinib may develop because the genes that code for BCR-ABL can mutate. Side effects of imatinib are not dose-dependent. Imatinib has significant drug interactions with several drugs. Imatinib is given orally.